As medications like 'Wegovy' and 'Ozempic' (GLP‑1 receptor agonists) become more common in weight‑loss strategies, US ...

Wegovy, a weight loss drug, is gaining popularity for its effectiveness, but experts emphasize that it's most successful when ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

The NHS has approved medications such as Mounjaro and Wegovy to tackle obesity and diabetes, with private prescriptions also ...

Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of U.S. pharmacy claims.

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...

A doctor has revealed 'maintaining nutrition' while on weight-loss drugs like Mounjaro is 'crucial' for long-term health amid worrying survey results.

Oprah Winfrey's decades-long weight loss journey, marked by public scrutiny and personal challenges, took a turn after knee ...

Weight loss jabs such as Wegovy and Mounjaro could be handed out “on the high street, or at any out-of-two shopping centre”, ...

With new leadership and a Nasdaq relisting plan, the iconic brand is betting on women’s health and weight loss drugs to stage ...